1. A Novel Intronic KMT2D Variant as a Cause of Kabuki Syndrome: A Case Report
- Author
-
Harry Pachajoa, Estephania Candelo, Lorena Díaz-Ordoñez, and Erica Aristizábal
- Subjects
Coloboma ,Pathology ,medicine.medical_specialty ,Kabuki syndrome ,RNA splicing ,Hearing loss ,Genetic disorder ,rare disease ,Case Report ,Biology ,medicine.disease ,sensorineural hearing loss ,Palpebral fissure ,coloboma ,Genetics ,medicine ,Sensorineural hearing loss ,medicine.symptom ,Gene ,Genetics (clinical) ,Rare disease - Abstract
Kabuki syndrome (KS) is an autosomal dominant genetic disorder in which most cases are caused by de novo mutations. KS type 1 is caused by mutations in KMT2D (OMIM: #147920) and is more common. KS type 2 is caused by mutations in KDM6A (OMIM: #300867). Both genes encode proteins that modify histones and are involved in epigenetic regulation. The enzyme histone-lysine N-methyltransferase 2D, the product of KMT2D, is expressed in most adult tissues and is essential for early embryonic development. The main clinical manifestations of KS include dysmorphic facial features, such as elongated palpebral fissures, eversion of the lateral third of the lower eyelids, and short nasal columella with a broad and depressed nasal tip. Additionally, patients also present with skeletal abnormalities, dermatoglyphic features, mild-to-moderate intellectual disability, hearing loss, and postnatal growth deficiency. We describe an 11-year-old girl from Colombia, who presented with characteristic clinical signs of KS. Genetic studies showed a KMT2D intronic variant (KMT2D NM_003482.3: c.511‐2A> T) as a cause of KS.
- Published
- 2021